NIZI; Emanuela

Patent Applications and Registrations

Patent applications and USPTO patent grants for NIZI; Emanuela.The latest application filed is for "use of perhexiline".

Company Profile

0.9.12

NIZI; Emanuela - Pomezia - Roma IT
Nizi; Emanuela - Pomezia IT
NIZI; Emanuela - Pomezia RM
Nizi; Emanuela - Ariccia IT
Nizi; Emanuela - Siena IT
Nizi; Emanuela - Rome IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Perhexiline App 20170157102 - RUBERTI; Giovina ; et al.	2017-06-08
Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDAC Grant 9,371,295 - Altamura , et al. June 21, 2	2016-06-21
Compounds for use in the treatment of parasitic diseases Grant 9,365,541 - Altamura , et al. June 14, 2	2016-06-14
Compounds For Use In The Treatment Of Parasitic Diseases App 20150299163 - ALTAMURA; Sergio ; et al.	2015-10-22
Compounds For Use In The Treatment Of Disorders That Are Ameliorated By Inhibition Of Hdac App 20150218112 - Altamura; Sergio ; et al.	2015-08-06
Macrocyclic compounds as antiviral agents Grant 8,178,520 - Di Francesco , et al. May 15, 2	2012-05-15
N-substituted Hydroxypyrimidinone Carboxamide Inhibitors Of Hiv Integrase App 20110034449 - Crescenzi; Benedetta ; et al.	2011-02-10
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,820,660 - Crescenzi , et al. October 26, 2	2010-10-26
Macrocyclic Compounds As Antiviral Agents App 20090258891 - Di Francesco; Maria Emilia ; et al.	2009-10-15
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase Grant 7,459,452 - Di Francesco , et al. December 2, 2	2008-12-02
N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase App 20080275004 - Crescenzi; Benedetta ; et al.	2008-11-06
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,435,734 - Crescenzi , et al. October 14, 2	2008-10-14
(4, 5, 6, 7-Tetrahydro-1-H-Indol-7-Yl) Acetic Acid Derivatives for Treatment of Alzheimer's Disease App 20070232678 - Bettati; Michela ; et al.	2007-10-04
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase Grant 7,232,819 - Di Francesco , et al. June 19, 2	2007-06-19
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase App 20070123524 - Crescenzi; Benedetta ; et al.	2007-05-31
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,217,713 - Crescenzi , et al. May 15, 2	2007-05-15
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase App 20070083045 - Di Francesco; Maria E. ; et al.	2007-04-12
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,169,780 - Crescenzi , et al. January 30, 2	2007-01-30
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase App 20060258860 - Crescenzi; Benedetta ; et al.	2006-11-16
Dihydroxypyrimidine carboxamide inhibitors of hiv integrase App 20050075356 - Di Francesco, Maria E. ; et al.	2005-04-07
N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase App 20050025774 - Crescenzi, Benedetta ; et al.	2005-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.